The presence of a positive sentinel node leads to a lymph node dissection of the invaded area, and subsequently, to adjuvant treatment with anti-PD1 immunotherapy or with BRAF inhibitors (BRAFi), depending on whether the tumour harbours a BRAF codon 600 mutation. This evidence concerns the gene BRAF and neoplasm.